UROTHELIAL CARCINOMA RECURRENT

Clinical trials for UROTHELIAL CARCINOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new UROTHELIAL CARCINOMA RECURRENT trials appear

Sign up with your email to follow new studies for UROTHELIAL CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New Two-Drug attack on tough bladder cancer shows promise

Disease control Recruiting now

This study is testing whether a new drug, either alone or combined with an immunotherapy drug, can help control advanced bladder cancer that has spread and has a specific marker called HER2. It will involve about 96 adults whose cancer has progressed despite prior treatments. The…

Matched conditions: UROTHELIAL CARCINOMA RECURRENT

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

UROTHELIAL CARCINOMA RECURRENT

Get alerted when new UROTHELIAL CARCINOMA RECURRENT trials appear

New Two-Drug attack on tough bladder cancer shows promise